Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

NCT00291343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Tritanrix™- HepB
BIOLOGICAL: Hiberix™
BIOLOGICAL: Mencevax™ ACWY

Sponsor

GlaxoSmithKline